CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 4 Grant or award Director acquired 1,738 shares (grant or award)
- 4 Grant or award SEE REMARKS acquired 15,639 shares (grant or award)
- 4 Grant or award Director acquired 1,640 shares (grant or award)
- 4 Grant or award Director acquired 2,197 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 14,736 shares (grant or award)
- 4 Grant or award Director acquired 69,784 shares (grant or award)
- 4 Grant or award SEE REMARKS acquired 17,916 shares (grant or award)
- 4 Grant or award SEE REMARKS acquired 21,158 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 71,715 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF BUSINESS OFFICER acquired 9,525 shares (grant or award)
- 4 Open-market sale SEE REMARKS sold 60 shares at $28.55 ($1,713)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 60 shares at $28.54 ($1,712)
- 4 Open-market sale SEE REMARKS sold 73 shares at $28.53 ($2,083)
- 4 Open-market sale SEE REMARKS sold 62 shares at $28.54 ($1,769)
Page 5 of 15 · 288 filings